Hepatoprotective role of ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice

Table 2 Effect of Ganoderma lucidum polysaccharide (GLP) on the granuloma formation (numbers/microscopic view) in BCG -pretrested mice hepatic histological slides. (¯x ± s)

Croup	Granulomas
Control	0
BCG (125 mg·kg-1)	64.67 ± 4.97b
BCG (125 mg·kg-1) + LPS (125 μg·kg-1)	54.40 ± 4.93b
BCG (125 mg·kg-1) + GLP (50 mg·kg-1)	60.00 ± 4.24b
BCG (125 mg·kg-1) + GLP (100 mg·kg-1)	4.00 ± 1.22bd
BCG (125 mg·kg-1) + GLP (200 mg·kg-1)	36.80 ± 5.81bd

^aP < 0.05,

^bP < 0.01 compared with control. ^cP < 0.05,

^dP < 0.01 compared with BCG-pretreated group. n = 5 microscopic views.